Navigation Links
EPEMED, the European Personalised Medicine Association, Appoints Executive Director
Date:6/2/2010

PARIS, June 3, 2010 /PRNewswire/ -- The personalised medicine association EPEMED, a European not-for-profit organisation bringing together global forces in personalised medicine, has today announced the appointment of Dr. Anne Bruinvels, an entrepreneur in personalised healthcare, as Executive Director and board member. Dr. Bruinvels will be responsible for growing the start-up organisation and, together with the board of directors, for building its strategic framework in creating guidance for all those involved in progressing personalised medicine with an emphasis on European market challenges.

"I'm very pleased with the appointment of Dr. Anne Bruinvels as Executive Director and board member of EPEMED," said Alain Huriez, MD, Founder and President of EPEMED. "Her proven leadership and communication skills in the personalised medicine field will benefit the association greatly and I look forward to working with her to bring harmonisation and education to the personalised medicine field in Europe. "

Dr. Anne Bruinvels stated, "I'm delighted to join EPEMED's board and to lead the association to facilitate the development and introduction of personalised medicine in Europe. I'm looking forward to working with the different parties worldwide involved in making real progress in this field."

To date, Europe is faced with a number of challenges to successfully develop innovative and effective, personalised medicine treatments. EPEMED's objectives are to develop

    1. A central point of communication for the different parties
       involved in progressing personalised medicine

    2. Optimal routes to deliver personalised medicine treatments
       to patients

    3. A greater understanding of the clinical development of
       personalised therapeutics through the creation and application of
       advanced diagnostic tests

Dr. Bruinvels started her work in personalised medicine more than 10 years ago. She has previously founded Elixior, a personalised healthcare advisory company and prior to that Curidium, a personalised medicine company identifying companion diagnostics and therapeutics to treat patients with central nervous system disorders. She was Curidium's CEO for more than six years and raised several rounds of funding before taking the company public on the AIM of the London Stock Exchange. Anne Bruinvels has also worked in research for various pharmaceutical companies, including SmithKline Beecham, Wyeth and Sandoz Pharma. She obtained her PhD (neuroscience) from Utrecht University (the Netherlands) and her MSc (pharmacy) from Groningen University (The Netherlands).

EPEMED is a recently formed, not-for-profit organisation. The association was founded to address issues in personalised medicine that confront the industry, regulators, payers & insurers as well as governments. EPEMED aims to provide a platform for the harmonisation of personalised medicine development and implementation across Europe, focussing on the crucial role of diagnostics, to make personalised medicine a reality. The organisation is directed by a dynamic and diverse group of leaders in the personalised medicine field, who have great expertise in the application and development of diagnostic tools to deliver improved patient care.

About Personalised Medicine

Recent innovations in molecular diagnostics have played an important role in improving patient outcomes in a range of human diseases. Jointly with personalised therapeutics, companion diagnostics form the field of personalised medicine, where a person's clinical, genomic and environmental information is used to more precisely select medication and dose for each individual patient. The application of personalised medicine is likely to improve patient care as well as lower healthcare costs.

EPEMED (c) 2010. All rights reserved.


'/>"/>
SOURCE EPEMED
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007
2. Boston Scientific Announces Schedule for European Society of Cardiology Congress 2007
3. European Experts Recommend Pregnant and Nursing Women Take More DHA - Every Day
4. Genasense(R) Data in Melanoma to be Presented in Opening Session at First Worldwide Melanoma Center Meeting of the European Association of Dermato-Oncology
5. Terumo Heart to Announce Results of European Clinical Trial of DuraHeart(TM) LVAS at European Association of Cardiothoracic Surgeons Meeting in September
6. Threshold Pharmaceuticals Announces Two Presentations on Glufosfamide at the 2007 European Cancer Conference (ECCO)
7. Study Results for Aclidinium Bromide, a Novel Anticholinergic, Presented at European Respiratory Society Annual Congress
8. Life Recovery Systems Receives European CE Mark Approval for Its ThermoSuit(R) System
9. Lilly Files for European Approval of ALIMTA(R) (pemetrexed for injection) for First-Line Treatment of Non-Small Cell Lung Cancer
10. European Unions CHMP Issues Positive Opinion on PEGINTRON(TM) Combination Therapy for Retreating Hepatitis C Patients Who Failed Previous Therapy
11. Positive Xeloda(R) Five-Year Overall Survival Study Data in the Adjuvant Treatment of Colon Cancer Presented at Leading European Cancer Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/23/2017)... , Feb. 23, 2017  Cogentix Medical, Inc. (NASDAQ: ... markets innovative proprietary products for the urology market, will ... year ended December 31, 2016 before the market open ... Company will host a conference call and webcast to ... March 9, 2017 at 11:00 a.m. Eastern Time (10:00 ...
(Date:2/23/2017)... -- Research and Markets has announced the addition of the ... their offering. ... research Menopause Drugs Price Analysis and Strategies - 2016, provides drug pricing ... the following questions: What are the key ... in the Global Menopause market? What are the unit ...
(Date:2/23/2017)... DUBLIN , Feb. 23, 2017 Research ... Price Analysis and Strategies - 2016" report to their offering. ... The latest ... pricing data and benchmarks in the global Fibromyalgia market. ... are the key drugs marketed for Fibromyalgia and their clinical attributes? ...
Breaking Medicine Technology:
(Date:2/24/2017)... ... , ... With millions of Americans and people worldwide struggling ... are aware of our options and are empowered with strength and information throughout ... its newest edition of "Vision and Hearing" in USA Today, that will educate ...
(Date:2/24/2017)... ... , ... The narrative in “ Signal 8: An Australian Paramedic’s Story ” ... paramedic experiences. Schanssema describes the tragedies he saw, as well as his struggles with ... Schanssema, initially unsure of the career path he wanted to take, found fulfillment in ...
(Date:2/24/2017)... ... February 24, 2017 , ... The California State University ... academic faculty engaged in or interested in palliative care education and research. The Symposium, ... held in North County San Diego on Sept. 28 and 29, 2017, on the ...
(Date:2/24/2017)... ... ... The International Association of Eating Disorders Professionals (iaedp) announces the 2017 top five ... art competition. Selected from 15 submissions from around the nation, the top five finalists ... iaedp Symposium, March 22 – 26 in Las Vegas. , This year, the competition ...
(Date:2/24/2017)... ... 2017 , ... The Radiology Business Management Association will select the ... annual Building Better Radiology Marketing Programs conference, held this year from March ... Nine awards are given out in five categories. They are:, , ...
Breaking Medicine News(10 mins):